Top broker says CBA (ASX:CBA) is 'on its way back'

Australia's largest bank could be in the buy zone…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The team at Bell Potter believe CBA is 'on its way back' to top line growth potential
  • Its analysts see a lot of value in the CBA share price at the current level
  • The broker also expects growing dividends in the coming years

The Commonwealth Bank of Australia (ASX: CBA) share price has started the week in the red.

In afternoon trade, the banking giant's shares are down almost 1% to $93.20.

CBA share price represented by branch welcome sign

Image Source: Commonwealth Bank

Is the weakness in the CBA share price a buying opportunity?

One leading broker that is likely to see the weakness in the CBA share price as a buying opportunity is Bell Potter.

Earlier this month, in response to the bank's half year results, the broker upgraded its shares to a buy rating with a $108.00 price target.

Based on the current CBA share price, this implies potential upside of 16% for investors over the next 12 months.

And if you include the fully franked dividend of $3.87 per share Bell Potter is expecting in FY 2022, the total return increases by an additional 4.1% to over 20%.

'On its way back'

Bell Potter is positive on the CBA share price due to its belief that the banking giant is on its way back to delivering revenue growth again.

The broker commented: "Despite the misgivings of the market and especially COVID-19's Omicron strain, CBA sees FY22 as a strong year. The unemployment (and underemployment rate) are the lowest since 2008 and Australian household accumulated savings are stronger than ever (likewise the rate at which wage growth in anticipated). Inflation is likely to increase in due course (and that's a good thing for all banks) while non-mining investment including infrastructure continue to hold up reasonably well. The bank has again bounced back from its lows and is on its way back to its usual top line growth potential."

Bell Potter expects this to underpin growing dividend payments in the coming years. It has pencilled in fully franked dividends per share of 387 cents in FY 2022, 407 cents in FY 2023, and 423 cents in FY 2024.

All in all, this could make the CBA share price a good option for investors looking for exposure to the banking sector.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »